Fatigue sebagai Gejala Sisa COVID-19

Brigitta Gladiola, Budi Riyanto Wreksoatmodjo


COVID-19 merupakan penyakit akibat infeksi Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). Dewasa ini, makin banyak penelitian menunjukkan adanya gejala menetap pasca-infeksi COVID-19. Prevalensi pasien pasca-COVID-19 yang memiliki gejala fatigue pada 1-3 bulan pasca-infeksi mencapai 52-70%. Beberapa teori mekanisme fatigue pasca-infeksi COVID-19 antara lain teori disfungsi hipotalamus dan teori GABA. Tata laksana pasien pasca-infeksi COVID-19 dengan gejala fatigue masih perlu diteliti lebih lanjut. Beberapa anjuran intervensi yaitu berolahraga, terapi mindfulness, latihan pernapasan, serta peregangan tubuh/stretching. Sampai saat ini, belum ada tata laksana berbasis bukti ilmiah untuk mengatasi gejala fatigue pasca-infeksi COVID-19.

COVID-19 is an infection caused by Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). There is an increasing data on the clinical manifestations of post COVID-19. Around 52-70% individuals recovering from COVID-19 complains of fatigue. Two leading theories of its mechanisms include hypothalamus dysfunction theory and GABA theory. More studies are needed to fully understand the mechanism of post COVID-19 fatigue. There is no specific treatment available, but some interventions such as exercise, mindfulness therapy, and body stretching can be used to ease post COVID-19 fatigue.

Full Text:



World Health Organization. Coronavirus Disease 2019 [Internet]. Available from: https://covid19.who.int/region/searo/country/id

García-Azorín D, Abildúa M, Aguirre M, Fernández SF, Moncó J, Guijarro-Castro C, et al. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry. J Neurological Sci. 2021;423:117283.

Carlos CR, Gerardo MM, Jaime OG, Isauro GHL, Dios APJ. Prevalence of neurological manifestations in COVID-19 and their association with mortality. Neurol Perspect. 021;1(1):11–6.

Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: Post- viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055.

Lucchese G, Flöel A. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons. Autoimmunity Rev 2020;19(7):102556.

Island T. Evaluation and treatment coronavirus (COVID-19) StatPearls [Internet][Google Scholar]. 2020.

Da Rosa Mesquita R, Francelino Silva Jr, LC, Santos Santana FM, Farias de Oliveira T, Campos Alcântara R, Monteiro Arnozo G, et al. Clinical manifestations of COVID-19 in the general population: Systematic review. Wiener Klinische Wochenschrift 2021;133(7-8):377–82. https://doi.org/10.1007/s00508-020-01760-4

McIntosh K, Hirsch M, Bloom A. COVID-19: Clinical features. Uptodate.com [Internet]. 2021 [cited 11 September 2021]. Available from: https://www.uptodate.com/contents/covid-19-clinical-features

Central for Disease Control and Prevention. Coronavirus; SARS-CoV-2 and surface transmission for indoor community environment [Internet]. 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/surface-transmission.html

Crook H, Raza S, Nowell J, Young M, Dison P. Long covid—mechanisms, risk factors, and management. BMJ 2021;374:1648.

World Health Organization. Public health surveillance for COVID-19: Interim guidance [Internet]. 2020. Available from: https://www.who.int/publications/i/item/who-2019-nCoV- surveillanceguidance-2020.7

Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: A case report. E-Neurological Sci. 2020;21:100276

O’Regan C, Cronin H, Kenny RA. The Irish longitudinal study on ageing: Mental health and cognitive function. TILDA; 2018.

Yelland GW. Gluten-induced cognitive impairment (“brain fog”) in coeliac disease. J Gastroenterol Hepatol. 2017;32:90–3. doi:10.1111/jgh.13706.

Ortelli P, Ferrazzoli D, Sebastianelli L, Engl M, Romanello R, Nardone R, et al. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom. J Neurol Sci. 2021;420:117271.

Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: An overview and approach to classification. Open Forum Infect Dis. 2020;7(12):ofaa509. doi: 10.1093/ofid/ofaa509.

Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–5. doi: 10.1001/jama.2020.12603.

Royal College of Occupational Therapists. How to conserve your energy: Practical advice for people during and after having COVID-19 [Internet]. 2020. Available from: https://www.rcot.co.uk/conserving-energy.

Maccarone MC, Magro G, Tognolo L, Masiero S. Post COVID-19 persistent fatigue: A proposal for rehabilitative interventions in the spa setting. Int J Biometeorol. 2021;65(12):2241-3. doi:10.1007/s00484-021-02158-1

Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: A population-based study. Int J Environ Res Public Health. 2021;18(4):2030. doi:10.3390/ijerph18042030

Eyles C, Leydon GM, Hoffman CJ, Copson ER, Prescott P, Chorozoglou M, et al. Mindfulness for the self-management of fatigue, anxiety, and depression in women with metastatic breast cancer: A mixed methods feasibility study. Integr Cancer Ther. 2015;14(1):42-56. doi:10.1177/1534735414546567

Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martinez-Cava A, Franco-Lopez F, Martinez BJS, et al. Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Publ Health. 2021;18(10):5329. doi:10.3390/ijerph18105329

Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Zoller t, Steinbeis F, et al. Chronic COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) following the first pandemic wave in Germany – a first analysis of a prospective observational study. medRxiv. 2021;02.06.21249256. doi: 10.1101/2021.02.06.21249256


  • There are currently no refbacks.